Split History
SNPX split history picture
Synaptogenix (SNPX) has 1 split in our SNPX split history database. The split for SNPX took place on April 05, 2024. This was a 1 for 25 reverse split, meaning for each 25 shares of SNPX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.

When a company such as Synaptogenix conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the SNPX split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Synaptogenix shares, starting with a $10,000 purchase of SNPX, presented on a split-history-adjusted basis factoring in the complete SNPX split history. SNPX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/06/2021
End date: 06/21/2024
Start price/share: $40.00
End price/share: $4.23
Dividends collected/share: $0.00
Total return: -89.42%
Average Annual Total Return: -47.81%
Starting investment: $10,000.00
Ending investment: $1,057.60
Years: 3.45
Synaptogenix is a biopharmaceutical company. Co. is focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. Co. is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing. Co. has completed an additional analysis in connection with the confirmatory Phase 2 study, which examined moderately severe to severe AD patients treated with Bryostatin-1 in the absence of memantine. According to our SNPX split history records, Synaptogenix has had 1 split.
Date Ratio
04/05/20241 for 25
SNPX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SNSS Split History
SONN Split History
SPEX Split History
SQL Split History
SRDX Split History
SRGA Split History
SRPT Split History
SRRA Split History
SSH Split History
SSKN Split History

Also explore: SNPX shares outstanding history

Email EnvelopeFree SNPX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Crown Electrokinetics Corp. (CRKN)
Medalist Diversified REIT, Inc. (MDRR)
Medalist Diversified REIT, Inc. (MDRR)
Qilian International Holding Group Limited (QLI)
Bluejay Diagnostics, Inc. (BJDX)
Atara Biotherapeutics, Inc. (ATRA)
GRI Bio, Inc. (GRI)
Williams-Sonoma, Inc. (WSM)
Workhorse Group Inc. (WKHS)
Virgin Galactic Holdings, Inc. (SPCE)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

SNPX Insider Buying

SNPX Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.